vimarsana.com

Latest Breaking News On - Precision coatings - Page 1 : vimarsana.com

Medical Coating Market 2023-2030 by Segmentation Based on Product, Application, End User and Region | Surmodics Inc , Hydromer Inc , Precision Coatings Co Inc , AST Products Inc |

Medical Coating Market 2023-2030 by Segmentation Based on Product, Application, End User and Region | Surmodics Inc , Hydromer Inc , Precision Coatings Co Inc , AST Products Inc |
medgadget.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medgadget.com Daily Mail and Mail on Sunday newspapers.

Envestnet Asset Management Inc Sells 1,723 Shares of Materion Co (NYSE:MTRN)

Envestnet Asset Management Inc. lowered its stake in Materion Co. (NYSE:MTRN – Get Rating) by 3.0% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 55,371 shares of the basic materials company’s stock after selling 1,723 shares during the period. Envestnet Asset Management Inc.’s holdings in Materion were worth $4,430,000 as of its most […]

Materion (NYSE:MTRN) Lowered to Hold at StockNews com

Materion (NYSE:MTRN – Get Rating) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a note issued to investors on Saturday. Separately, KeyCorp boosted their price objective on Materion from $92.00 to $130.00 and gave the stock an “overweight” rating in a report on Friday, February 17th. Materion […]

New York State Common Retirement Fund Sells 5,818 Shares of Materion Co (NYSE:MTRN)

New York State Common Retirement Fund decreased its holdings in Materion Co. (NYSE:MTRN – Get Rating) by 9.5% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 55,412 shares of the basic materials company’s stock after selling 5,818 shares during the […]

Materion Co (NYSE:MTRN) Given Consensus Recommendation of Buy by Brokerages

Shares of Materion Co. (NYSE:MTRN – Get Rating) have been assigned a consensus rating of “Buy” from the six research firms that are covering the company, Marketbeat reports. Two research analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 12 month price target […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.